QINGSONG HEALTH(02661.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
QINGSONG HEALTH
02661.HK
QingSong Health Corporation provide digital integrated healthcare and health insurance solutions in China. It offers early disease screening related promotion and consultancy, health examination and consultation, medical appointment services, and health supplement sales. It offers services through Weixin official accounts, mini Programs, WeCom accounts, and website. QingSong Health Corporation was formerly known as QingSongChou Corporation and changed its name to QingSong Health Corporation in September 2020.
4.233 T
02661.HKMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Morning Trend | QINGSONG HEALTH observes with reduced volume, waiting for changes amid sector rotation

    QINGSONG HEALTH (2661.HK) has recently entered a period of low trading volume and observation, with frequent sector rotations leading to a relatively flat performance. Yesterday, the stock price fluctuated slightly, with the 5-day and 10-day moving averages showing a convergence state. The MACD golden cross signal continues but with noticeably weakened strength, indicating a decrease in market participants' subjectivity. The trading volume in the intraday gap is sparse, suggesting that a wait-and-see sentiment dominates the current market. From a sector perspective, after the previous hot rotation in the healthcare track, funds have begun to focus on second-tier pharmaceutical targets with relatively high cost-performance ratios. QINGSONG HEALTH has a relatively stable fundamental outlook, with optimized business structure and user growth bringing potential for the medium to long term. However, there are limited short-term benefits from news, and the speed of expectation fulfillment is slow, resulting in recent performance lagging behind sector leaders. Technically, the stock is currently positioned around multiple moving average centers. If there are favorable policies or industry catalysts in the future, it may help stabilize and raise the stock price. If the sector continues to rotate and the intensity of capital inflow does not increase, it may face a probability of box oscillation. It is recommended that investors maintain patience in the short term and avoid blindly chasing prices, closely monitor intraday fluctuations and marginal changes in industry policies, and wait for clear signals before increasing positions in the medium term

    Technical Forecast·
    HK
    02661
    +8.30%
    Technical Forecast·
    HK
    02661
    +8.30%

    Top 10 HK Stock Gainers (12.24)

    BIOCYTOGEN-B(02315) rose 22.23%, with a trading turnover 482.4 Million HKD, and a year-to-date rose 312.7%. BWI INT'L(02339) rose 15.48%, with a trading turnover 31.1 Million HKD, and a year-to-date rose 2142.8%. QINGSONG HEALTH(02661) rose 13.8%, with a trading turnover 46.1 Million HKD, and a year-to-date rose 194.5%.

    Top Gainers & Losers·
    HK
    02315
    +0.65%
    HK
    02339
    +4.05%
    HK
    02661
    +8.30%
    Top Gainers & Losers·
    HK
    02315
    +0.65%
    HK
    02339
    +4.05%
    HK
    02661
    +8.30%

    The dark market closing price of QINGSONG HEALTH for the new stock was HKD 51.7, 128% higher than the listing price

    QINGSONG HEALTH performed strongly in the dark market, closing at HKD 51.7, up 128% from the listing price. The Phillip platform showed it opened 23% higher, while the Futu platform indicated an opening increase of 58.7%. The trading volumes were 1.47 million shares and 1.2472 million shares, with respective amounts of HKD 69.3 million and HKD 58.6643 million. Each lot consists of 200 shares, resulting in a paper profit of HKD 5,804

    AASTOCKS·
    HK
    02661
    +8.30%
    AASTOCKS·
    HK
    02661
    +8.30%

    Qingsong Health Corp Says Total Number Of Offer Shares Under Global Offering 26.5 Mln Shares

    Qingsong Health Corp:TOTAL NUMBER OF OFFER SHARES UNDER GLOBAL OFFERING 26.5 MILLION SHARESOFFER PRICE OF HK$22.68 PER SHARE UNDER GLOBAL OFFERINGNUMBER OF INTERNATIONAL OFFER SHARES 23.9 MILLION IN GLOBAL OFFERING

    Reuters·
    HK
    02661
    +8.30%
    Reuters·
    HK
    02661
    +8.30%
    © 2026 Longbridge｜Disclaimer